IPG Investment Advisors’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,148
| Closed | -$45K | – | 169 |
|
|
2022
Q2 | $45K | Buy |
+1,148
| New | +$45K | 0.01% | 145 |
|
|
2021
Q2 | – | Sell |
-648
| Closed | -$34K | – | 200 |
|
|
2021
Q1 | $34K | Buy |
+648
| New | +$34K | 0.01% | 189 |
|
|
2019
Q3 | – | Sell |
-200
| Closed | -$8.57K | – | 145 |
|
|
2019
Q2 | $8.57K | Sell |
200
-650
| -76% | -$27.8K | ﹤0.01% | 144 |
|
|
2019
Q1 | $46.3K | Buy |
850
+300
| +55% | +$16.4K | 0.02% | 148 |
|
|
2018
Q4 | $16.4K | Buy |
+550
| New | +$16.4K | 0.01% | 143 |
|
|
2017
Q4 | – | Sell |
-890
| Closed | -$58.7K | – | 162 |
|
|
2017
Q3 | $58.7K | Buy |
890
+100
| +13% | +$6.6K | 0.02% | 140 |
|
|
2017
Q2 | $66.8K | Buy |
790
+100
| +14% | +$8.45K | 0.03% | 133 |
|
|
2017
Q1 | $95.6K | Buy |
+690
| New | +$95.6K | 0.04% | 128 |
|